For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
POC Glycated Hemoglobin Analyzer is the Point-of-care Glycated Hemoglobin Analyzer, which is defined as a medical diagnostic analyzer at or near the point of carethat is, at the time and place of patient care.
Glycated hemoglobin (HbA1c) levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.
The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.
LPI (LP Information)' newest research report, the "POC Glycated Hemoglobin Analyzer Industry Forecast" looks at past sales and reviews total world POC Glycated Hemoglobin Analyzer sales in 2022, providing a comprehensive analysis by region and market sector of projected POC Glycated Hemoglobin Analyzer sales for 2023 through 2029. With POC Glycated Hemoglobin Analyzer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POC Glycated Hemoglobin Analyzer industry.
This Insight Report provides a comprehensive analysis of the global POC Glycated Hemoglobin Analyzer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POC Glycated Hemoglobin Analyzer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global POC Glycated Hemoglobin Analyzer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POC Glycated Hemoglobin Analyzer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POC Glycated Hemoglobin Analyzer.
The global POC Glycated Hemoglobin Analyzer market size is projected to grow from US$ 634.6 million in 2022 to US$ 1022.6 million in 2029; it is expected to grow at a CAGR of 1022.6 from 2023 to 2029.
The classification of POC Glycated Hemoglobin Analyzer includes Bench-top, Compact, Portable, and the proportion of bench-top is about 49%.
POC Glycated Hemoglobin Analyzer is widely used in hospitals, labs and other place. The most proportion of POC Glycated Hemoglobin Analyzer is used in hospitals, and the proportion is about 52%.
Europe is the largest supplier of POC Glycated Hemoglobin Analyzer, with a production market share nearly 48%. North Amerca is the second largest supplier of POC Glycated Hemoglobin Analyzer, enjoying production market share nearly 33%.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
Market competition is not intense. Alere, Siemens, Roche, Trinity Biotech, GREEN CROSS MEDIS and EKF Diagnostics, etc. are the leaders of the industry, with about 70% market shares.
This report presents a comprehensive overview, market shares, and growth opportunities of POC Glycated Hemoglobin Analyzer market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Bench-Top
- Compact
- Portable
Segmentation by application
- Hospital
- Lab
- Others
The below companies that are profiled
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Alere
- Siemens
- Roche
- Trinity Biotech
- GREEN CROSS MEDIS
- EKF Diagnostics
- OSANG Healthcare
- HUMAN Diagnostics
- Erba Diagnostics
- PTS Diagnostics
- Liteon Technology
- DiaSys Diagnostic
- Convergent Technologies
Key Questions Addressed in this Report
What is the 10-year outlook for the global POC Glycated Hemoglobin Analyzer market?
What factors are driving POC Glycated Hemoglobin Analyzer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do POC Glycated Hemoglobin Analyzer market opportunities vary by end market size?
How does POC Glycated Hemoglobin Analyzer break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?